Is Methotrexate safe in pregnancy?

Common uses

Cancer, psoriasis, rheumatoid arthritis, ectopic pregnancy treatment

How Methotrexate works and why pregnancy changes the math

Methotrexate is a chemotherapeutic agent that interferes with folate metabolism and cell division. The same mechanism that lets it treat cancer, severe rheumatoid arthritis, and ectopic pregnancy makes it incompatible with normal fetal development. Methotrexate is one of the strongest known teratogens.

For anyone planning pregnancy who has been on methotrexate, the standard recommendation is to stop the medication at least three months before conception to allow it to clear from tissues. Folate supplementation alongside that washout period is important. For someone who learns they are pregnant while on methotrexate, this is a maternal-fetal medicine consultation immediately — both for assessment of fetal effects and for management of the underlying condition with pregnancy-safe alternatives.

How Methotrexate risk changes by trimester

The clinical reasoning behind the verdict

Highly teratogenic. Stop 3 months before conception.

Dosing and what to do if symptoms keep going

Pregnancy dosing for Methotrexate generally follows standard adult guidance unless your provider has directed otherwise. Pregnancy changes how your body absorbs, distributes, and clears many medications, so doses that worked before may need adjustment as pregnancy progresses.

If symptoms are not responding to standard dosing of Methotrexate, that is a conversation with your prescriber rather than a reason to escalate on your own. Pregnancy is a time when changes to medication should happen with provider involvement, both because the underlying condition may be evolving and because pregnancy-safe alternatives may be available.

Safer alternatives and how to choose between them

Switch to pregnancy-safe alternatives well before conception.

For medications with the most serious pregnancy contraindications, the alternatives depend entirely on what condition is being treated. The plan should be discussed with the prescribing specialist before pregnancy if possible, with enough lead time to switch and stabilize on the alternative.

For someone who learns they are pregnant while on a strongly teratogenic medication, an immediate conversation with both the prescriber and an obstetrician is the right next step. Some of these medications can be stopped immediately; others need a planned taper. None of them should continue at full dose without an active risk-benefit conversation specific to your situation.

What recent research has been saying about Methotrexate

The literature on Methotrexate in pregnancy continues to evolve as more population-level data accumulates and as researchers control more carefully for confounding factors. The pregnancy-specific evidence base for any given medication is rarely as deep as the general adult evidence base, so cautious clinical interpretation and individualized provider conversation remain the right approach as guidance updates.

Sources and further reading

FDA Methotrexate Warning